Latest News

08

February 2017

iX Biopharma Ltd. has reported results for the second financial quarter ended 31 December 2016...

Read On

21

November 2016

iX Biopharma Ltd. is pleased to announce that it has been granted a patent in South Africa for its WaferiX™ drug delivery technology...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com